Clin2
NCT06845254Worth exploringNot yet recruiting

Xuesaitong capsules for heart patients after stent procedure

Acute Coronary Syndrome

Part of Heart & circulation clinical trials.

This study tests a Chinese herbal medicine called Xuesaitong soft capsules for people who recently had a heart attack or unstable angina and had a stent placed. The goal is to see if taking these capsules helps improve heart health after the procedure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
400 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You have recently had a heart attack or unstable angina.
  • In the last 4 weeks, you had a procedure to open a blocked heart artery (like angioplasty with a stent).
  • You are between 18 and 80 years old.
  • You do not have high bleeding risk (e.g., recent bleeding stroke, aneurysm, surgery, or active bleeding).
  • You do not have a history of stomach ulcers or bleeding, severe heart disease, liver/kidney failure, or cancer.
  • You are not pregnant, breastfeeding, or planning pregnancy, and you don't have issues with alcohol/drugs or allergies to required medications.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06425120Recruiting· Phase 4
Xuesaitong for heart disease risk factors

This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.

Beijing, Beijing Municipality
NCT07041359Recruiting· Phase 4
Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms

This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.

Beijing, Beijing Municipality
NCT06855537Recruiting· Phase 4
Stent for vulnerable plaques in heart patients

This trial tests whether implanting stents in non-obstructive, high-risk plaques (thin-capped fatty plaques) can prevent future heart attacks. It is for people who have already had treatment for a recent heart attack or unstable angina and have additional plaques that are not severely blocking blood flow but are vulnerable.

Beijing, Beijing Municipality
NCT07616544Not yet recruiting· Phase 3
Herbal granules after heart stent procedure

This trial tests whether a traditional Chinese herbal medicine called Qidan Xiaoke granules can help people who have had a heart stent placed. It aims to see if the granules improve recovery and reduce future heart problems.

NCT07621107Not yet recruiting· Phase 2
Guanxinning tablet to improve heart blood flow after a heart attack

This study tests whether a traditional Chinese medicine called Guanxinning Tablet can help improve blood flow in the tiny vessels of the heart after a heart attack treated with a stent. It may help your heart recover better and reduce future heart problems.

NCT07493603Recruiting· Phase 1/Phase 2
Herbal medicine study for chest pain after stent placement

This trial tests a traditional Chinese herbal formula, Yiyang Huoluo Decoction, for people who still have chest discomfort after getting a stent for coronary heart disease. It aims to see if the herbal treatment can improve symptoms.

Huzhou, Zhejiang

Hear when a new Acute Coronary Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.